Global Daprodustat API Manufacturer | Amber Lifesciences

Daprodustat API is an innovative pharmaceutical ingredient used to treat anemia associated with chronic kidney disease (CKD). As a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), it helps stimulate the body’s natural production of erythropoietin, improving red blood cell formation. With the increasing prevalence of kidney disorders worldwide, demand for Daprodustat API is growing among pharmaceutical manufacturers seeking advanced therapies for anemia management.

Daprodustat API – Key Information

Product Name: Daprodustat API
Generic Name: Daprodustat
CAS Number: 960539-70-2
Molecular Formula: C19H27N3O6
Molecular Weight: 393.44 g/mol

Pharmacological Class

  • Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI) – Stimulates endogenous erythropoietin production by stabilizing hypoxia-inducible factors.
  • Anemia Management API – Used in the treatment of anemia associated with chronic kidney disease.
  • Renal Care Therapy API – Supports red blood cell production in CKD patients.
  • Nephrology Health API – Contributes to improved management of kidney disease-related complications.
  • Active Pharmaceutical Ingredient (API) – Widely used in the manufacturing of oral formulations for anemia treatment.

North America Leads Daprodustat Market Growth

Among global regions, the United States represents one of the highest-potential markets for Daprodustat API due to its large CKD patient population, advanced healthcare infrastructure, and strong pharmaceutical sector. North America continues to witness increasing adoption of innovative renal disease treatments. Additionally, growing healthcare expenditure and awareness of anemia management contribute to expanding opportunities for Daprodustat-based formulations throughout the region.

Rising Applications In Renal Disease

Daprodustat API is primarily utilized in the production of medications for treating anemia caused by chronic kidney disease in dialysis and non-dialysis patients. The increasing global incidence of diabetes, hypertension, and kidney-related complications has significantly boosted the demand for effective anemia therapies. Pharmaceutical companies are actively investing in novel formulations to address unmet medical needs and improve patient outcomes.

Regulatory Compliance Requirements For Market

Manufacturers supplying Daprodustat API to international markets must comply with stringent regulatory standards. Regulatory authorities require adherence to Good Manufacturing Practices (GMP), detailed quality documentation, stability studies, and comprehensive safety data. Compliance with standards established by agencies such as the U.S. FDA, EMA, and other regional regulators is essential for successful product registration and market entry.

Import Registration Process For Daprodustat

The import and registration process varies by country but generally includes dossier submission, API specifications, manufacturing certifications, analytical reports, and regulatory approvals. Importers often need Drug Master Files (DMF), Certificates of Analysis (COA), and GMP certifications before obtaining authorization. Working with experienced API manufacturers simplifies the registration process and ensures compliance with local pharmaceutical regulations.

Emerging Opportunities Across Global Regions

The global market for Daprodustat API presents significant growth opportunities, particularly in North America, Europe, Asia-Pacific, and Latin America. Rising chronic kidney disease prevalence, increasing healthcare investments, and expanding access to advanced treatments are driving market expansion. Pharmaceutical companies seeking innovative renal care solutions are expected to increase procurement of high-quality Daprodustat API, creating favorable opportunities for manufacturers and exporters.

Amber Lifesciences Ensures Quality Manufacturing

Amber Lifesciences is committed to delivering high-quality pharmaceutical APIs that meet international standards. The company follows stringent quality control procedures and advanced manufacturing practices to ensure product consistency, purity, and regulatory compliance. With strong export capabilities, comprehensive documentation support, and a customer-focused approach, Amber Lifesciences serves pharmaceutical companies seeking reliable Daprodustat API supply solutions worldwide.

Frequently Asked Questions About Daprodustat

Q1. What is Daprodustat API used for?
Daprodustat API is used in medications designed to treat anemia associated with chronic kidney disease.

Q2. Which region has the highest market potential?
North America, particularly the United States, currently represents a leading market due to strong healthcare infrastructure and high CKD prevalence.

Q3. What regulatory documents are required?
Common requirements include GMP certificates, DMF, COA, stability data, and product specifications.

Q4. Why is demand for Daprodustat increasing?
The growing number of chronic kidney disease patients and demand for innovative anemia therapies are driving market growth.

Q5. Why choose Amber Lifesciences?
Amber Lifesciences offers high-quality manufacturing, regulatory support, international compliance, and reliable API supply for global pharmaceutical markets.